Regeneron Q1 profit soars - News - Dukascopy Bank

Thu, 06 May 2021 11:22:16 GMT
Source: Dukascopy Bank SA
 
On Thursday, Regeneron Pharmaceuticals reported its Q1 profit surged as much as 78%, driven by strong demand recovery of its Eylea eye drug and ongoing strength in the Dupixent eczema drug's sales.

Back to feed
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.